Business Description
Better Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US08773T1043
Description
Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.46 | |||||
Equity-to-Asset | -0.93 | |||||
Debt-to-Equity | -1.44 | |||||
Debt-to-EBITDA | -0.54 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -84 | |||||
3-Year EPS without NRI Growth Rate | -90.4 | |||||
3-Year FCF Growth Rate | -50 | |||||
3-Year Book Growth Rate | 66.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 48 | |||||
9-Day RSI | 50.81 | |||||
14-Day RSI | 49.04 | |||||
6-1 Month Momentum % | -94.4 | |||||
12-1 Month Momentum % | -99.19 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.57 | |||||
Quick Ratio | 0.57 | |||||
Cash Ratio | 0.51 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.4 | |||||
Shareholder Yield % | -343.39 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -182.93 | |||||
ROIC % | -317.61 | |||||
ROC (Joel Greenblatt) % | -25053.3 | |||||
ROCE % | -642.62 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.28 | |||||
EV-to-EBITDA | -0.31 | |||||
EV-to-FCF | -0.31 | |||||
Earnings Yield (Greenblatt) % | -357.14 | |||||
FCF Yield % | -4017.74 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BTTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Better Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -1.15 | ||
Beta | 0 | ||
Volatility % | 117.51 | ||
14-Day RSI | 49.04 | ||
14-Day ATR ($) | 0.004619 | ||
20-Day SMA ($) | 0.009286 | ||
12-1 Month Momentum % | -99.19 | ||
52-Week Range ($) | 0.005 - 1.35 | ||
Shares Outstanding (Mil) | 54.52 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Better Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Better Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Better Therapeutics Inc Frequently Asked Questions
What is Better Therapeutics Inc(BTTX)'s stock price today?
The current price of BTTX is $0.01. The 52 week high of BTTX is $1.35 and 52 week low is $0.01.
When is next earnings date of Better Therapeutics Inc(BTTX)?
The next earnings date of Better Therapeutics Inc(BTTX) is 2024-07-05 Est..
Does Better Therapeutics Inc(BTTX) pay dividends? If so, how much?
Better Therapeutics Inc(BTTX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |